These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33888122)

  • 1. The diagnostic utility of diffusion weighted MRI imaging and ADC ratio to distinguish benign from malignant renal masses: sorting the kittens from the tigers.
    de Silva S; Lockhart KR; Aslan P; Nash P; Hutton A; Malouf D; Lee D; Cozzi P; MacLean F; Thompson J
    BMC Urol; 2021 Apr; 21(1):67. PubMed ID: 33888122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtype Differentiation of Small (≤ 4 cm) Solid Renal Mass Using Volumetric Histogram Analysis of DWI at 3-T MRI.
    Li A; Xing W; Li H; Hu Y; Hu D; Li Z; Kamel IR
    AJR Am J Roentgenol; 2018 Sep; 211(3):614-623. PubMed ID: 29812980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic test accuracy of ADC values for identification of clear cell renal cell carcinoma: systematic review and meta-analysis.
    Tordjman M; Mali R; Madelin G; Prabhu V; Kang SK
    Eur Radiol; 2020 Jul; 30(7):4023-4038. PubMed ID: 32144458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small (< 4 cm) Renal Tumors With Predominantly Low Signal Intensity on T2-Weighted Images: Differentiation of Minimal-Fat Angiomyolipoma From Renal Cell Carcinoma.
    Park JJ; Kim CK
    AJR Am J Roentgenol; 2017 Jan; 208(1):124-130. PubMed ID: 27824487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of diffusion-weighted MRI and contrast-enhanced MRI for differentiation between solid renal masses and renal cell carcinoma subtypes.
    Serter A; Onur MR; Coban G; Yildiz P; Armagan A; Kocakoc E
    Abdom Radiol (NY); 2021 Mar; 46(3):1041-1052. PubMed ID: 32930832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade.
    Mytsyk Y; Dutka I; Borys Y; Komnatska I; Shatynska-Mytsyk I; Farooqi AA; Gazdikova K; Caprnda M; Rodrigo L; Kruzliak P
    Int Urol Nephrol; 2017 Feb; 49(2):215-224. PubMed ID: 27853915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted imaging versus contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomas.
    Zhong Y; Wang H; Shen Y; Guo A; Wang J; Kang S; Ma L; Pan J; Ye H
    Eur Radiol; 2017 Dec; 27(12):4913-4922. PubMed ID: 28631081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Multiparametric MRI Useful for Differentiating Oncocytomas From Chromophobe Renal Cell Carcinomas?
    Galmiche C; Bernhard JC; Yacoub M; Ravaud A; Grenier N; Cornelis F
    AJR Am J Roentgenol; 2017 Feb; 208(2):343-350. PubMed ID: 27959744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of renal cell carcinoma, oncocytoma, and lipid-poor angiomyolipoma by unenhanced, nephrographic, and delayed phase contrast-enhanced computed tomography.
    Ishigami K; Pakalniskis MG; Leite LV; Lee DK; Holanda DG; Rajput M
    Clin Imaging; 2015; 39(1):76-84. PubMed ID: 25457535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
    Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
    AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility and limitations of 3-Tesla diffusion-weighted magnetic resonance imaging for differentiation of renal tumors.
    Sevcenco S; Heinz-Peer G; Ponhold L; Javor D; Kuehhas FE; Klingler HC; Remzi M; Weibl P; Shariat SF; Baltzer PA
    Eur J Radiol; 2014 Jun; 83(6):909-913. PubMed ID: 24709332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted imaging using 3.0 T MRI as a possible biomarker of renal tumors.
    Mirka H; Korcakova E; Kastner J; Hora M; Hes O; Hosek P; Ferda J
    Anticancer Res; 2015 Apr; 35(4):2351-7. PubMed ID: 25862900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
    Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
    Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT.
    Gentili F; Bronico I; Maestroni U; Ziglioli F; Silini EM; Buti S; de Filippo M
    Radiol Med; 2020 Dec; 125(12):1280-1287. PubMed ID: 32385827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma.
    Pierorazio PM; Hyams ES; Tsai S; Feng Z; Trock BJ; Mullins JK; Johnson PT; Fishman EK; Allaf ME
    Urology; 2013 Jun; 81(6):1265-71. PubMed ID: 23601445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours.
    Cornelis F; Tricaud E; Lasserre AS; Petitpierre F; Bernhard JC; Le Bras Y; Yacoub M; Bouzgarrou M; Ravaud A; Grenier N
    Eur Radiol; 2014 May; 24(5):1068-80. PubMed ID: 24557052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Cell Carcinoma or Oncocytoma? The Contribution of Diffusion-Weighted Magnetic Resonance Imaging to the Differential Diagnosis of Renal Masses.
    Metin M; Aydın H; Karaoğlanoğlu M
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208545
    [No Abstract]   [Full Text] [Related]  

  • 19. Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT.
    Sasaguri K; Takahashi N; Gomez-Cardona D; Leng S; Schmit GD; Carter RE; Leibovich BC; Kawashima A
    AJR Am J Roentgenol; 2015 Nov; 205(5):999-1007. PubMed ID: 26496547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Biexponential and Monoexponential Model of Diffusion-Weighted Imaging for Distinguishing between Common Renal Cell Carcinoma and Fat Poor Angiomyolipoma.
    Ding Y; Zeng M; Rao S; Chen C; Fu C; Zhou J
    Korean J Radiol; 2016; 17(6):853-863. PubMed ID: 27833401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.